oseen · source-linked reporting

The U.S. Food and Drug Administration approves Gilead Sciences's new lenacapavir drug, marketed as Yeztugo,

Management of HIV/AIDS — The U.S. Food and Drug Administration approves Gilead Sciences's new lenacapavir drug, marketed as Yeztugo, for the treatment of HIV after successful clinical trials show the drug

Published June 18, 2025· Updated October 28, 2026·1 min read

Context: Management of HIV/AIDS.

The U.S. Food and Drug Administration approves Gilead Sciences's new lenacapavir drug, marketed as Yeztugo, for the treatment of HIV after successful clinical trials show the drug nearly eliminated the infection spread. [https://www.nbcnews.com/health/health-news/fda-hiv-prevention-drug-prep-lenacapavir-rcna208387 (NBC News)] [https://apnews.com/article/hiv-prevention-shot-lenacapavir-gilead-80fb37e2c5ac9b452488d7b86a10d568 (AP)]

Event summary via Wikipedia Current Events (2025-06-18).